Annual FCF
-$5.20 M
+$1.42 M+21.41%
31 December 2023
Summary:
INVO Bioscience annual free cash flow is currently -$5.20 million, with the most recent change of +$1.42 million (+21.41%) on 31 December 2023. During the last 3 years, it has fallen by -$335.70 thousand (-6.90%). INVO annual FCF is now -514.06% below its all-time high of $1.26 million, reached on 31 December 2019.INVO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$640.81 K
+$869.99 K+57.58%
30 September 2024
Summary:
INVO Bioscience quarterly free cash flow is currently -$640.81 thousand, with the most recent change of +$869.99 thousand (+57.58%) on 30 September 2024. Over the past year, it has increased by +$714.69 thousand (+52.73%). INVO quarterly FCF is now -121.08% below its all-time high of $3.04 million, reached on 31 March 2019.INVO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$3.25 M
+$714.69 K+18.02%
30 September 2024
Summary:
INVO Bioscience TTM free cash flow is currently -$3.25 million, with the most recent change of +$714.69 thousand (+18.02%) on 30 September 2024. Over the past year, it has increased by +$2.16 million (+39.94%). INVO TTM FCF is now -234.14% below its all-time high of $2.42 million, reached on 31 March 2019.INVO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INVO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.4% | +52.7% | +39.9% |
| 3 y3 years | -6.9% | +72.8% | +54.5% |
| 5 y5 years | -673.3% | -3.6% | -286.8% |
INVO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.9% | +21.4% | -106.5% | +72.8% | at high | +56.6% |
| 5 y | 5 years | -514.1% | +21.4% | -106.5% | +72.8% | -286.8% | +56.6% |
| alltime | all time | -514.1% | +21.4% | -121.1% | +72.8% | -234.1% | +56.6% |
INVO Bioscience Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$640.81 K(-57.6%) | -$3.25 M(-18.0%) |
| June 2024 | - | -$1.51 M(+386.9%) | -$3.97 M(-9.1%) |
| Mar 2024 | - | -$310.30 K(-60.7%) | -$4.36 M(-16.1%) |
| Dec 2023 | -$5.20 M(-21.4%) | -$789.90 K(-41.7%) | -$5.20 M(-4.0%) |
| Sept 2023 | - | -$1.36 M(-28.9%) | -$5.41 M(-5.2%) |
| June 2023 | - | -$1.91 M(+65.9%) | -$5.71 M(+0.5%) |
| Mar 2023 | - | -$1.15 M(+14.4%) | -$5.68 M(-14.2%) |
| Dec 2022 | -$6.62 M(+2.0%) | -$1.00 M(-39.2%) | -$6.62 M(-2.6%) |
| Sept 2022 | - | -$1.65 M(-12.0%) | -$6.80 M(-9.4%) |
| June 2022 | - | -$1.88 M(-10.0%) | -$7.50 M(+10.2%) |
| Mar 2022 | - | -$2.08 M(+76.2%) | -$6.80 M(+4.9%) |
| Dec 2021 | -$6.48 M(+33.3%) | -$1.18 M(-49.8%) | -$6.48 M(-9.3%) |
| Sept 2021 | - | -$2.36 M(+99.7%) | -$7.15 M(+24.1%) |
| June 2021 | - | -$1.18 M(-33.1%) | -$5.76 M(+0.4%) |
| Mar 2021 | - | -$1.76 M(-4.7%) | -$5.74 M(+18.0%) |
| Dec 2020 | -$4.86 M(-487.3%) | -$1.85 M(+91.1%) | -$4.86 M(+28.5%) |
| Sept 2020 | - | -$968.70 K(-16.2%) | -$3.78 M(+10.2%) |
| June 2020 | - | -$1.16 M(+30.0%) | -$3.43 M(+28.5%) |
| Mar 2020 | - | -$888.60 K(+15.2%) | -$2.67 M(-312.8%) |
| Dec 2019 | $1.26 M(-286.8%) | -$771.10 K(+24.7%) | $1.26 M(-27.9%) |
| Sept 2019 | - | -$618.50 K(+56.9%) | $1.74 M(-22.4%) |
| June 2019 | - | -$394.30 K(-113.0%) | $2.24 M(-7.5%) |
| Mar 2019 | - | $3.04 M(-1161.7%) | $2.42 M(-471.2%) |
| Dec 2018 | -$672.40 K(+270.9%) | -$286.30 K(+144.5%) | -$653.00 K(+69.1%) |
| Sept 2018 | - | -$117.10 K(-44.8%) | -$386.20 K(+30.3%) |
| June 2018 | - | -$212.20 K(+467.4%) | -$296.50 K(+180.0%) |
| Mar 2018 | - | -$37.40 K(+91.8%) | -$105.90 K(-41.6%) |
| Dec 2017 | -$181.30 K(-46.6%) | -$19.50 K(-28.8%) | -$181.30 K(-32.4%) |
| Sept 2017 | - | -$27.40 K(+26.9%) | -$268.00 K(-12.3%) |
| June 2017 | - | -$21.60 K(-80.9%) | -$305.60 K(-20.4%) |
| Mar 2017 | - | -$112.80 K(+6.2%) | -$383.70 K(+13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$339.60 K(+124.0%) | -$106.20 K(+63.4%) | -$339.60 K(+1.1%) |
| Sept 2016 | - | -$65.00 K(-34.8%) | -$336.00 K(+13.5%) |
| June 2016 | - | -$99.70 K(+45.1%) | -$296.10 K(+47.2%) |
| Mar 2016 | - | -$68.70 K(-33.0%) | -$201.20 K(+32.6%) |
| Dec 2015 | -$151.60 K(+681.4%) | -$102.60 K(+308.8%) | -$151.70 K(+209.0%) |
| Sept 2015 | - | -$25.10 K(+422.9%) | -$49.10 K(+104.6%) |
| June 2015 | - | -$4800.00(-75.0%) | -$24.00 K(+25.0%) |
| Mar 2015 | - | -$19.20 K(-141.5%) | -$19.20 K(-83.7%) |
| Dec 2014 | -$19.40 K(-67.6%) | - | - |
| Dec 2013 | -$59.90 K(+38.7%) | - | - |
| Dec 2012 | -$43.20 K(-63.3%) | - | - |
| Dec 2011 | -$117.80 K(-62.7%) | $46.30 K(-179.4%) | -$117.70 K(+140.2%) |
| Sept 2011 | - | -$58.30 K(+36.9%) | -$49.00 K(-62.7%) |
| June 2011 | - | -$42.60 K(-32.5%) | -$131.40 K(-33.2%) |
| Mar 2011 | - | -$63.10 K(-154.9%) | -$196.80 K(-37.7%) |
| Dec 2010 | -$316.00 K(-65.9%) | $115.00 K(-181.7%) | -$316.10 K(-53.8%) |
| Sept 2010 | - | -$140.70 K(+30.3%) | -$684.50 K(-21.2%) |
| June 2010 | - | -$108.00 K(-40.8%) | -$868.50 K(+4.9%) |
| Mar 2010 | - | -$182.40 K(-28.0%) | -$828.20 K(-10.6%) |
| Dec 2009 | -$926.70 K(-18.7%) | -$253.40 K(-22.0%) | -$926.80 K(-48.4%) |
| Sept 2009 | - | -$324.70 K(+379.6%) | -$1.80 M(+35.9%) |
| June 2009 | - | -$67.70 K(-75.9%) | -$1.32 M(-6.2%) |
| Mar 2009 | - | -$281.00 K(-75.0%) | -$1.41 M(+23.6%) |
| Dec 2008 | -$1.14 M(+8741.1%) | -$1.12 M(-850.0%) | -$1.14 M(+6131.7%) |
| Sept 2008 | - | $149.80 K(-196.5%) | -$18.30 K(-89.2%) |
| June 2008 | - | -$155.20 K(+1249.6%) | -$169.50 K(+597.5%) |
| Mar 2008 | - | -$11.50 K(+721.4%) | -$24.30 K(+86.9%) |
| Dec 2007 | -$12.90 K(+1190.0%) | -$1400.00(0.0%) | -$13.00 K(+12.1%) |
| Sept 2007 | - | -$1400.00(-86.0%) | -$11.60 K(+13.7%) |
| June 2007 | - | -$10.00 K(+4900.0%) | -$10.20 K(+5000.0%) |
| Mar 2007 | - | -$200.00 | -$200.00 |
| Dec 2006 | -$1000.00 | - | - |
FAQ
- What is INVO Bioscience annual free cash flow?
- What is the all time high annual FCF for INVO Bioscience?
- What is INVO Bioscience annual FCF year-on-year change?
- What is INVO Bioscience quarterly free cash flow?
- What is the all time high quarterly FCF for INVO Bioscience?
- What is INVO Bioscience quarterly FCF year-on-year change?
- What is INVO Bioscience TTM free cash flow?
- What is the all time high TTM FCF for INVO Bioscience?
- What is INVO Bioscience TTM FCF year-on-year change?
What is INVO Bioscience annual free cash flow?
The current annual FCF of INVO is -$5.20 M
What is the all time high annual FCF for INVO Bioscience?
INVO Bioscience all-time high annual free cash flow is $1.26 M
What is INVO Bioscience annual FCF year-on-year change?
Over the past year, INVO annual free cash flow has changed by +$1.42 M (+21.41%)
What is INVO Bioscience quarterly free cash flow?
The current quarterly FCF of INVO is -$640.81 K
What is the all time high quarterly FCF for INVO Bioscience?
INVO Bioscience all-time high quarterly free cash flow is $3.04 M
What is INVO Bioscience quarterly FCF year-on-year change?
Over the past year, INVO quarterly free cash flow has changed by +$714.69 K (+52.73%)
What is INVO Bioscience TTM free cash flow?
The current TTM FCF of INVO is -$3.25 M
What is the all time high TTM FCF for INVO Bioscience?
INVO Bioscience all-time high TTM free cash flow is $2.42 M
What is INVO Bioscience TTM FCF year-on-year change?
Over the past year, INVO TTM free cash flow has changed by +$2.16 M (+39.94%)